Hematology News and Research

RSS
Hematology, also spelled haematology, is the branch of biology (physiology), pathology, clinical laboratory, internal medicine, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases.

Further Reading

Alexion Pharmaceuticals reports interim results from phase 1 trial on samalizumab antibody

Alexion Pharmaceuticals reports interim results from phase 1 trial on samalizumab antibody

6 Dec 2010
Study compares efficacy of two treatments for iron overload caused by chronic transfusion therapy

Study compares efficacy of two treatments for iron overload caused by chronic transfusion therapy

6 Dec 2010
Positive results from pivotal trial of SGN-35 in refractory Hodgkin lymphoma presented at ASH 2010

Positive results from pivotal trial of SGN-35 in refractory Hodgkin lymphoma presented at ASH 2010

6 Dec 2010
Research reveals new standard treatment options for various forms of lymphoma

Research reveals new standard treatment options for various forms of lymphoma

6 Dec 2010
Study: REVLIMID and dexamethasone for high-risk smoldering multiple myeloma reduce risk of disease progression

Study: REVLIMID and dexamethasone for high-risk smoldering multiple myeloma reduce risk of disease progression

6 Dec 2010
Clinical data of PCI-32765 in patients with CLL presented at ASH Annual Meeting

Clinical data of PCI-32765 in patients with CLL presented at ASH Annual Meeting

6 Dec 2010
New studies answer questions related to stem cell transplant procedures in treating hematologic malignancies

New studies answer questions related to stem cell transplant procedures in treating hematologic malignancies

6 Dec 2010
UIC scientist focuses on potential targets to inhibit malaria transmission

UIC scientist focuses on potential targets to inhibit malaria transmission

6 Dec 2010
Phase 2 survival data of sapacitabine in patients with MDS presented at ASH Annual Meeting

Phase 2 survival data of sapacitabine in patients with MDS presented at ASH Annual Meeting

6 Dec 2010
Investigational study data of REVLIMID with rituximab or rituximab-containing regimen in CLL patients presented at ASH

Investigational study data of REVLIMID with rituximab or rituximab-containing regimen in CLL patients presented at ASH

6 Dec 2010
Pivotal PROPEL trial data of FOLOTYN in patients with refractory PTCL reported at ASH Annual Meeting

Pivotal PROPEL trial data of FOLOTYN in patients with refractory PTCL reported at ASH Annual Meeting

6 Dec 2010
New drug for non-Hodgkin’s lymphoma shows promise

New drug for non-Hodgkin’s lymphoma shows promise

5 Dec 2010
Clinical studies participated by three investigators to be presented at ASH Annual Meeting and Exposition

Clinical studies participated by three investigators to be presented at ASH Annual Meeting and Exposition

4 Dec 2010
Pfizer plans regulatory submissions of bosutinib for CML based on BELA study

Pfizer plans regulatory submissions of bosutinib for CML based on BELA study

4 Dec 2010
Onconova announces three presentations on Estybon- (ON 01910.Na) at ASH 2010

Onconova announces three presentations on Estybon- (ON 01910.Na) at ASH 2010

4 Dec 2010
Merck to present multiple clinical studies of dinaciclib at ASH Annual Meeting

Merck to present multiple clinical studies of dinaciclib at ASH Annual Meeting

4 Dec 2010
MDS Foundation: Significant advances made in understanding, treating MDS, AML

MDS Foundation: Significant advances made in understanding, treating MDS, AML

4 Dec 2010
New clues into mechanisms underlying antiphospholipid syndrome

New clues into mechanisms underlying antiphospholipid syndrome

4 Dec 2010
Key findings on plasma cell disorders to be presented at American Society of Hematology Annual Meeting

Key findings on plasma cell disorders to be presented at American Society of Hematology Annual Meeting

4 Dec 2010
SuperGen to present SGI-110 data for MDS, AML at ASH annual meeting

SuperGen to present SGI-110 data for MDS, AML at ASH annual meeting

3 Dec 2010

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback